A large randomised assessment of the relative cost-effectiveness of different classes of drugs for Parkinson's disease (PD MED)
Gray R, Rick C, Rowland N, Williams A, Gray A, Clarke C, Jenkinson C, Wheatley K
Record ID 32001000791
English
Details
Project Status:
Completed
URL for project:
https://www.journalslibrary.nihr.ac.uk/programmes/hta/980302/#/
Year Published:
2022
URL for published report:
https://fundingawards.nihr.ac.uk/award/98/03/02#/
Requestor:
NIHR Health Technology Assessment programme
URL for additional information:
https://fundingawards.nihr.ac.uk/award/98/03/02#/
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England, United Kingdom
MeSH Terms
- Parkinson Disease
- Cost-Benefit Analysis
- Drug Therapy
- Antiparkinson Agents
- Carbidopa
- Levodopa
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.